Both in Lab Analytical Instruments
Bio-Rad Laboratories vs 10x Genomics
Over the past year BIO returned +17.6% and TXG returned +349.9%; their daily moves had a correlation of 0.41.
BIO +17.6% TXG +349.9%Growth of $1, one year, split-adjusted
| Metric | BIO | TXG |
|---|---|---|
| Price | $366.16 | $61.63 |
| Market cap | $9.79B | $8.03B |
| Today | −1.62% | −12.10% |
| 1 month | −0.8% | −34.1% |
| 6 months | +42.0% | +184.7% |
| Year to date | +20.8% | +277.9% |
| 1 year | +20.2% | +395.4% |
| Revenue growth (YoY) | −0.1% | −12.6% |
| Gross margin | 53.1% | 74.5% |
| Net margin | 57.1% | −11.9% |
| P/E (TTM) | 44.0× | — |
| Price / sales | 3.8× | 13.0× |
| Net cash | $414.8M | $552.0M |
| Dividend yield | — | — |
| Volatility (60d) | 27.4% | 88.2% |
| Short % of float | 5.9% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).